CD8A and neoplasm: To determine the immune response involved in the rejection, female immunocompetent mice injected with Fhit-transfected B9/B11 tumor cell lines were depleted of CD4- or CD8-T-cells starting at 60 dpi, and a subsequent challenge with B9/B11 tumor cells was performed.